GGrantIndex
Sort

172,184 grants matching inflammation

Mucosal Immune Defense Mechanisms of the Urinary Bladder

$1,460,729
Marco Colonna · Washington University · U01 · FY2020 · AI

Cannabinoid-based therapy and approaches to quantify pain in sickle cell disease

$1,460,654
Kalpna Gupta · University Of Minnesota · U01 · FY2013 · HL

Epidemiologic Study of Hepatocellular Carcinoma in the US

$1,460,631
Herbert Yu · University Of Hawaii At Manoa · R01 · FY2015 · CA

Role of the Arterial Wall in Atherosclerosis

$1,460,383
Boston University Medical Campus · P01 · FY2003 · HL

Sensory Biology

$1,460,345
Nicholas J Ryba · National Institute Of Dental & Craniofacial Research · ZIA · FY2021 · DE

Center for Biomedical OCT Research and Translation

$1,460,266
Brett E Bouma · Massachusetts General Hospital · P41 · FY2016 · EB

JHU NIMH Center for Novel Therapeutics for HIV-associated Cognitive Disorders

$1,460,217
Norman J Haughey · Johns Hopkins University · P30 · FY2020 · MH

Innate inflammatory responses during pulmonary infections

$1,460,145
Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death

$1,460,069
Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2025 · AI

Airway inflammation and airway remodeling

$1,460,035
David H Broide · University Of California, San Diego · U19 · FY2014 · AI

Center for Novel Biomarkers of Response

$1,460,012
Joel G Pounds · Battelle Pacific Northwest Laboratories · U54 · FY2010 · ES

Costimulation and Cytokines in Tolerance

$1,459,884
Laurence A Turka · Beth Israel Deaconess Medical Center · P01 · FY2011 · AI

Functions and Mechanisms of NF-kB Factors and their Regulators

$1,459,824
Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Targeted Anticoagulant Therapy for Sickle Cell Disease

$1,459,516
Kenneth I Ataga · Univ Of North Carolina Chapel Hill · U01 · FY2015 · HL

Synthesis of Effective and Safe Mucolytics for Pulmonary Disease

$1,459,479
Richard C Boucher · Univ Of North Carolina Chapel Hill · UH2 · FY2014 · HL

Gene-Environment Interactions at the Skin Surface

$1,459,457
Julia Angela Segre · National Human Genome Research Institute · ZIA · FY2018 · HG

California National Primate Research Center

$1,459,457
Prasant Mohapatra · University Of California At Davis · P51 · FY2021 · OD

Development of Apo Mimetic Peptides for the Treatment Cardiovascular Disease

$1,459,268
Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL

Novel Reengineered Microbiome-based Biologic Therapy to Treat Cognitive and Behavioral Symptoms of Alzheimer's Disease and Related Dementias

$1,459,176
Anumantha Gounder Kanthasamy · University Of Georgia · U01 · FY2022 · AG

Environmental Health Sciences Research Center

$1,458,685
Peter S Thorne · University Of Iowa · P30 · FY2008 · ES

Nox family NADPH oxidases: roles in innate immunity and inflammatory disease

$1,458,602
Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI

Immune Function and the Progression to Type 1 Diabetes

$1,458,398
Mark A Atkinson · University Of Florida · P01 · FY2016 · AI

Mitochondrial Complex I as a Target for Neuroprotection in AD

$1,458,379
Eugenia Trushina · Mayo Clinic Rochester · RF1 · FY2025 · AG

Integrating NK and DC into Cancer Therapy

$1,458,286
Michael T Lotze · University Of Pittsburgh At Pittsburgh · P01 · FY2007 · CA

Effect of IL-4RαR576 variant on response to Dupilumab in children with Asthma

$1,458,175
Wanda Phipatanakul · Boston Children'S Hospital · U01 · FY2019 · AI